Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11269403 | 0.83 | PDCD1 (0.42) | ACHEPTGS2PTGS1 | |
| SCHEMBL28990346 | 0.80 | TSHR (0.40) | TDP1NPC1RAB9A | |
| SCHEMBL8819823 | 0.78 | PTGS2 (0.36) | TDP1PTGS2NPC1PTGS1 | |
| SCHEMBL4280005 | 0.76 | HPGDS (0.40) | PTGS2NPC1RAB9APTGS1 | |
| SCHEMBL2565144 | 0.74 | TDP1 (0.35) | ACHETDP1MEN1NPC1RAB9A | |
| SCHEMBL15453986 | 0.74 | ALDH1A1 (0.34) | TDP1MEN1RAB9AKMT2AMAOB | |
| SCHEMBL446052 | 0.74 | MAPT (0.37) | TDP1MEN1NPC1RAB9AKMT2A | |
| SCHEMBL4285266 | 0.71 | HSD17B1 (0.40) | PTGS2PTGS1 | |
| SCHEMBL16344216 | 0.71 | RAB9A (0.37) | ACHEMEN1NPC1RAB9AKMT2A | |
| SCHEMBL2834322 | 0.71 | PTGS2 (0.35) | ACHETDP1PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10640641-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2020-05-05 | — | — | US | disclosed |
| US-20200062953-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2020-02-27 | — | — | US | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| US-20180237635-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2018-08-23 | — | — | US | disclosed |
| US-9976028-B2 | Curable coating compositions of silane functional polymers | KING INDUSTRIES (US) | 2018-05-22 | — | — | US | disclosed |
| WO-2016137881-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES (US) | 2016-09-01 | — | — | WO | disclosed |
| US-20160244606-A1 | CURABLE COATING COMPOSITIONS OF SILANE FUNCTIONAL POLYMERS | KING INDUSTRIES | 2016-08-25 | — | — | US | disclosed |
| US-8912113-B2 | Compositions of a metal amidine complex and second compound, coating compositions comprising same | KING INDUSTRIES, INC. (US) | 2014-12-16 | — | — | US | disclosed |
| EP-2683767-A1 | COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME | KING INDUSTRIES, INC. (US) | 2014-01-15 | — | — | EP | disclosed |
| WO-2012122098-A1 | COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME | KING INDUSTRIES, INC. (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120225982-A1 | COMPOSITIONS OF A METAL AMIDINE COMPLEX AND SECOND COMPOUND, COATING COMPOSITIONS COMPRISING SAME | KING INDUSTRIES, INC. | 2012-09-06 | — | — | US | disclosed |
| US-5879436-A | REACTION PRODUCT OF CARBOXYLIC ACID AND AMINOSILANE; PROTECTIVE COATINGS | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| US-5153306-A | AROMATIC POLYETHERS, FLUORESCENT RESIN COMPOSITIONS CONTAINING SAME, AND PROCESSES FOR PREPARING SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0164850-B1 | A NOVEL PROCESS FOR THE PREPARATION OF OXAZOLINES | ELI LILLY AND COMPANY (US) | 1989-03-22 | — | — | EP | disclosed |
| US-4587053-A | Preparation of oxazolines | ELI LILLY AND COMPANY (US) | 1986-05-06 | — | — | US | disclosed |
| EP-0164850-A1 | A novel process for the preparation of oxazolines | ELI LILLY AND COMPANY (US) | 1985-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | ACHE 330/4885TDP1 2226/4885PTGS2 3322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.